Clinical

Dataset Information

0

Effect of adjunctive metformin on recurrence of non-DM colorectal cancer


ABSTRACT: Interventions: Drug : This study is an open label randomized controlled clinical trial to examine the effect of adjunctive metformin on recurrence of non-DM colorectal cancer stage II high-risk/ III colorectal cancer. The 1g/day of metformin will be given to patients during adjuvant chemotherapy after surgery and continued for 4 years. Primary outcome(s): recurrence rate Primary Purpose : Prevention, Intervention Model : Parallel, Blinding/Masking : Open, Allocation : RCT

DISEASE(S): Neoplasms

PROVIDER: 2512203 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2203050 | ecrin-mdr-crc
2020-09-08 | GSE157585 | GEO
| 2377422 | ecrin-mdr-crc
| 2684682 | ecrin-mdr-crc
2018-09-14 | GSE119937 | GEO
2019-07-13 | E-MTAB-7272 | biostudies-arrayexpress
2023-11-02 | GSE236746 | GEO
2020-06-27 | GSE153318 | GEO
2012-05-20 | E-GEOD-36847 | biostudies-arrayexpress
2012-02-21 | E-GEOD-35961 | biostudies-arrayexpress